Quando nasci um anjo esbelto,desses que tocam trombeta, anunciou:vai carregar bandeira.Cargo muito pesado pra mulher,esta especie ainda envergonhada.Aceito os subterfugios que me cabem,sem precisar mentir.Nao sou feia que nao possa casar,acho o Rio de Janeiro uma beleza eora sim, ora nao, creio em parto sem dor.Mas o que sinto escrevo. Cumpro a sina.Inauguro linhagens, fundo reinos dor nao e amargura.Minha tristeza nao tem pedigree,ja a minha vontade de alegria,sua raiz vai ao meu mil avo.Vai ser coxo na vida e maldicao pra homem.Mulher e desdobravel. Eu sou. BOSTON (PRWEB) August 22, 2013Cambridge Semantics, leading provider of smart data solutions for the pharmaceutical industry, today announced its participation in the 2013 Pharma CI Conference & Exposition. Lee Feigenbaum, Vice President of Marketing and Technology for Cambridge Semantics, will present on pharma competitive intelligence (CI) solutions to automate data gathering, investigation and analytics to conference delegates. In addition, Cambridge Semantics is exhibiting at the conference.When: September 18, 2013 9:00 a.m. 9:35 a.m.Where: Pharma CI Conference & Exhibition Hilton East Brunswick Hotel 3 Tower Center Blvd. East Brunswick, New Jersey 08816Details: Large pharmaceutical organizations, like companies in many industries, face challenges with enterprise data management and end user data consumption. At Pharma CI Conference & Exposition, Feigenbaums presentation will introduce the concept of CI Informatics, technology solutions dedicated to gathering and distributing high-quality competitive intelligence information. Feigenbaums presentation will provide examples of CI Informatics in use based on Cambridge Semantics award-winning Anzo Pharma Competitive Intelligence solution.Using semantic technology, Anzo proactively gathers and routes relevant and targeted CI information to the right people at the right time, from the right information sources whether internal or external to the company, structured or unstructured. The software can be used for intelligence gathering across a number of use cases, including compound licensing, biopartnering, market intelligence, comparative effectiveness research, drug repositioning, self-service competitive intelligence reporting and analytics, and more.Cambridge Semantics Anzo platform has been deployed by R&D CI teams, business development and sourcing teams, marketing groups and knowledge management teams at a number of leading pharma companies, including Merck, Lilly, Novartis, Biogen and others.Media and analysts interested in a briefing with Cambridge Semantics, please contact Lora Friedrichsen at Cambridge(at)globalresultspr(dot)com or +1 949 608 0276.About Cambridge SemanticsCambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics or Facebook. By Megan Nicholson, Guest blogger / 09.03.13Last year Maryland Governor Martin OMalley asked the Energy Future Coalition (EFC), a project of the UN Foundation, to design a multi-faceted and comprehensive pilot-project plan for the states utilities. EFC assembled a stakeholder group including two Maryland utilities, PEPCO and Baltimore Gas & Electric Company (BGE), to submit ideas for pilot projects that could build a better utility future. The resulting report, Utility 2.0: Piloting the Future for Marylands Electric Utilities and their Customers, takes a different path than typical electricity utility reform strategies. Rather than dictating a single pathway for higher renewable penetration, the report calls for a number of pilot projects designed to create an entirely new grid system that advances innovation, resilience,